Bolag Altan

1.3k total citations
35 papers, 1000 citations indexed

About

Bolag Altan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Bolag Altan has authored 35 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Oncology and 7 papers in Surgery. Recurrent topics in Bolag Altan's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Bolag Altan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Bolag Altan collaborates with scholars based in Japan, United States and France. Bolag Altan's co-authors include Takehiko Yokobori, Hiroyuki Kuwano, Takayuki Asao, Masahiko Nishiyama, Kyoichi Kaira, Akira Mogi, Tetsunari Oyama, Akira Watanabe, Kenichiro Araki and Norio Kubo and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Carcinogenesis.

In The Last Decade

Bolag Altan

35 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bolag Altan Japan 19 593 388 308 158 106 35 1000
Lin Guo China 21 731 1.2× 332 0.9× 440 1.4× 180 1.1× 82 0.8× 71 1.3k
Alessia Noto Italy 17 479 0.8× 289 0.7× 370 1.2× 199 1.3× 59 0.6× 18 936
Monika Bauden Sweden 18 523 0.9× 634 1.6× 306 1.0× 172 1.1× 108 1.0× 32 1.1k
Wendy Prime United Kingdom 17 662 1.1× 358 0.9× 279 0.9× 138 0.9× 75 0.7× 24 1.1k
Chundong Gu China 20 535 0.9× 299 0.8× 238 0.8× 357 2.3× 77 0.7× 51 1.0k
Ryo Nagashio Japan 20 626 1.1× 300 0.8× 202 0.7× 225 1.4× 82 0.8× 56 1.0k
Sharon B. Sams United States 17 382 0.6× 514 1.3× 229 0.7× 208 1.3× 73 0.7× 40 1.0k
Michaela Medová Switzerland 20 650 1.1× 322 0.8× 189 0.6× 197 1.2× 98 0.9× 51 1.0k
Yunxiao Meng China 17 510 0.9× 261 0.7× 339 1.1× 97 0.6× 50 0.5× 32 909
Kathryn Effendi Japan 16 359 0.6× 232 0.6× 198 0.6× 110 0.7× 85 0.8× 23 766

Countries citing papers authored by Bolag Altan

Since Specialization
Citations

This map shows the geographic impact of Bolag Altan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolag Altan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolag Altan more than expected).

Fields of papers citing papers by Bolag Altan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bolag Altan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolag Altan. The network helps show where Bolag Altan may publish in the future.

Co-authorship network of co-authors of Bolag Altan

This figure shows the co-authorship network connecting the top 25 collaborators of Bolag Altan. A scholar is included among the top collaborators of Bolag Altan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bolag Altan. Bolag Altan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rokudai, Susumu, Bolag Altan, Tomonori Yoshida, et al.. (2017). Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma. Cancer Science. 108(11). 2149–2155. 10 indexed citations
2.
Shimizu, Kimihiro, Yoichi Ohtaki, Bolag Altan, et al.. (2017). Prognostic impact of stathmin 1 expression in patients with lung adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 154(4). 1406–1417.e3. 11 indexed citations
3.
Bao, Pinjie, Takehiko Yokobori, Bolag Altan, et al.. (2017). High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma. Annals of Surgical Oncology. 24(13). 4017–4024. 37 indexed citations
4.
Tsukagoshi, Mariko, Kenichiro Araki, Takehiko Yokobori, et al.. (2017). Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins. Oncotarget. 8(26). 42159–42172. 14 indexed citations
5.
Igarashi, Takamichi, Kenichiro Araki, Takehiko Yokobori, et al.. (2017). Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression. Oncotarget. 8(7). 12290–12300. 17 indexed citations
6.
Ishii, Norihiro, Kenichiro Araki, Takehiko Yokobori, et al.. (2017). Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1. Oncotarget. 8(68). 112636–112646. 22 indexed citations
7.
Bai, Tuya, Takehiko Yokobori, Bolag Altan, et al.. (2017). High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients. British Journal of Cancer. 116(9). 1177–1185. 49 indexed citations
8.
Suzuki, Shigemasa, Takehiko Yokobori, Bolag Altan, et al.. (2017). High stathmin 1 expression is associated with poor prognosis and chemoradiation resistance in esophageal squamous cell carcinoma. International Journal of Oncology. 50(4). 1184–1190. 20 indexed citations
9.
Kogure, Norimichi, Takehiko Yokobori, Kyoichi Ogata, et al.. (2017). Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis. Anticancer Research. 37(1). 191–196. 19 indexed citations
10.
Altan, Bolag, Kyoichi Kaira, Akira Watanabe, et al.. (2017). Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 81(1). 141–153. 42 indexed citations
11.
Kubo, Norio, Kenichiro Araki, Bolag Altan, et al.. (2017). Enhanced karyopherin-α2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms. Pancreatology. 17(4). 611–616. 7 indexed citations
12.
Watanabe, Akira, Kenichiro Araki, Takehiko Yokobori, et al.. (2017). Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms. Oncology Letters. 13(3). 1783–1788. 7 indexed citations
13.
Horiguchi, Jun, Toru Higuchi, Ayaka Katayama, et al.. (2017). Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients. International Journal of Oncology. 51(3). 781–790. 38 indexed citations
14.
Kimura, Akiharu, Kyoichi Ogata, Bolag Altan, et al.. (2016). Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer. Oncotarget. 7(14). 18415–18423. 34 indexed citations
15.
Araki, Kenichiro, Takehiko Yokobori, Norihiro Ishii, et al.. (2016). High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction. Journal of Surgical Oncology. 114(4). 462–468. 7 indexed citations
16.
Koga, Yasuhiko, Takahiro Satoh, Kyoichi Kaira, et al.. (2016). Elemental and immunohistochemical analysis of the lungs and hilar lymph node in a patient with asbestos exposure, a pilot study. Environmental Health and Preventive Medicine. 21(6). 492–500. 4 indexed citations
17.
Watanabe, Akira, Hideki Suzuki, Takehiko Yokobori, et al.. (2014). Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Science. 105(6). 690–696. 45 indexed citations
18.
Yokobori, Takehiko, Reina Yajima, Hiroki Morita, et al.. (2014). MicroRNA-7expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity viaEGFRregulation. Carcinogenesis. 36(3). 338–345. 107 indexed citations
19.
Yokobori, Takehiko, Akira Mogi, Hideki Endoh, et al.. (2013). FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs. Molecular Cancer Research. 12(1). 32–37. 47 indexed citations
20.
Watanabe, Akira, Hideki Suzuki, Takehiko Yokobori, et al.. (2013). Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis. Cancer Science. 104(11). 1427–1432. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Guo Breakdown of academic impact, for papers by Alessia Noto Breakdown of academic impact, for papers by Monika Bauden Breakdown of academic impact, for papers by Wendy Prime Breakdown of academic impact, for papers by Chundong Gu Breakdown of academic impact, for papers by Ryo Nagashio Breakdown of academic impact, for papers by Sharon B. Sams Breakdown of academic impact, for papers by Michaela Medová Breakdown of academic impact, for papers by Yunxiao Meng Breakdown of academic impact, for papers by Kathryn Effendi
Rankless by CCL
2026